Sugi Predict

Sugi Predict / Compounds / SCHEMBL6535307

SCHEMBL6535307

SCHEMBL6535307

CC(C)(C)OC(=O)NCCCCCC(=O)NCCCCCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.61
▸ CYP3A4 P08684 1/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ MAOA P21397 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ EPHX2 P34913 3/20 0.52
▸ CA1 P00915 5/20 0.50
▸ CA2 P00918 5/20 0.50
▸ CA12 O43570 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ ADRA1A P35348 1/20 0.50
▸ PRMT1 Q99873 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23616304 1.00 TDP1 (0.61) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL3288412 1.00 TDP1 (0.61) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL25827504 0.98 TDP1 (0.58) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL28348827 0.95 TDP1 (0.54) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL9554443 0.94 TDP1 (0.57) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL826329 0.94 TDP1 (0.69) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL7911543 0.94 TDP1 (0.69) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL22276602 0.94 TDP1 (0.69) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL22276615 0.94 TDP1 (0.69) TDP1CYP3A4MEN1GAAKMT2A
SCHEMBL826376 0.94 TDP1 (0.69) TDP1CYP3A4MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108472381-B Compounds and therapeutic uses thereof 森陶里治疗有限公司 2023-06-06 — — CN disclosed
US-20220373541-A1 Tri-functional Crosslinking Reagents ETH ZURICH (CH) 2022-11-24 — — US disclosed
US-11385225-B2 Tri-functional crosslinking reagents ETH ZURICH (CH) 2022-07-12 — — US disclosed
US-11385225-B2 Tri-functional crosslinking reagents ETH ZURICH (CH) 2022-07-12 — — US disclosed
US-20210369850-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF Centauri Therapeutics Limited (GB/GB) (GB) 2021-12-02 — — US disclosed
EP-3374348-B1 TRI-FUNCTIONAL CROSSLINKING REAGENTS ETH ZUERICH (CH) 2021-11-24 — — EP disclosed
US-10953100-B2 Compounds and therapeutic uses thereof CENTUARI THERAPEUTICS LIMITED (GB/GB) (GB) 2021-03-23 — — US disclosed
US-20180328922-A1 TRI-FUNCTIONAL CROSSLINKING REAGENTS ETH ZURICH (CH) 2018-11-15 — — US disclosed
US-20180280521-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF CENTUARI THERAPEUTICS LIMITED (GB/GB) (GB) 2018-10-04 — — US disclosed
CN-108472381-A COMPOUNDS AND THERAPEUTIC USES THEREOF 森陶里治疗有限公司 2018-08-31 — — CN disclosed
US-20100048890-A1 CONJUGATED SMALL MOLECULES DISCOVERX CORPORATION 2010-02-25 — — US disclosed
US-20080234464-A1 Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same CREDIA JAPAN CO., LTD. (JP) 2008-09-25 — — US disclosed
EP-0842418-A4 COMPOSITE MEMBRANE SENSOR AMBRI LTD (AU) 2004-08-18 — — EP disclosed
US-6740213-B2 VARIOUS ZONES; MEMBRANE CONTAINING IONOPHORES AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) 2004-05-25 — — US disclosed
US-20010030132-A1 Composite membrane sensor AMBRI LIMITED (AU) 2001-10-18 — — US disclosed
US-6210551-B1 Composite membrane sensor AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) 2001-04-03 — — US disclosed
EP-0383803-B1 OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES HOWARD FLOREY INST OF (AU) 2000-05-03 — — EP disclosed
EP-0972779-A2 Oligonucleotide-polyamide conjugates HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2000-01-19 — — EP disclosed
EP-0842418-A1 COMPOSITE MEMBRANE SENSOR AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) 1998-05-20 — — EP disclosed
WO-1997005477-A1 COMPOSITE MEMBRANE SENSOR AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) 1997-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048890-A1 CONJUGATED SMALL MOLECULES ERBB2, ALK, ACP1 TDP1 3880/4885CYP3A4 4556/4885MEN1 4141/4885
US-11385225-B2 Tri-functional crosslinking reagents ADGRF1, FCGR3B, FCGR2A TDP1 3834/4885CYP3A4 1283/4885MEN1 4550/4885
US-20220373541-A1 Tri-functional Crosslinking Reagents ADGRF1, SIGLEC7, ADGRE5 TDP1 3238/4885CYP3A4 1058/4885MEN1 4585/4885
US-20210369850-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF CD47, MYD88, NFATC1 TDP1 2823/4885CYP3A4 4064/4885MEN1 907/4885
US-20180328922-A1 TRI-FUNCTIONAL CROSSLINKING REAGENTS ADGRF1, FCGR3B, FCGR2A TDP1 3834/4885CYP3A4 1283/4885MEN1 4550/4885
US-20080234464-A1 Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same NGLY1, ELOVL6, ELOVL1 TDP1 4663/4885CYP3A4 3375/4885MEN1 1011/4885
US-10953100-B2 Compounds and therapeutic uses thereof CD47, MYD88, NFATC1 TDP1 2823/4885CYP3A4 4064/4885MEN1 907/4885
US-20180280521-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF CD47, MYD88, NFATC1 TDP1 2823/4885CYP3A4 4064/4885MEN1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.